• Hospital practice (1995) · Feb 2010

    Review

    Methicillin-resistant Staphylococcus aureus in community-acquired and health care-associated pneumonia: incidence, diagnosis, and treatment options.

    • Nathan Dean.
    • Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT 84107, USA. nathan.dean@imail.org
    • Hosp Pract (1995). 2010 Feb 1;38(1):7-15.

    AbstractPneumonia is one of the leading causes of death in the United States. As health care has expanded into community settings, including outpatient clinics, long-term care facilities, and dialysis centers, a new category of pneumonia-health care-associated pneumonia (HCAP)-has been defined. Bacterial resistance to antibiotics is rising among community-acquired infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) infections, particularly the severe form of necrotizing pneumonia mediated by USA 300 in young and healthy individuals, warrants attention. Although Streptococcus pneumoniae remains the most prevalent causative pathogen in community-acquired pneumonia (CAP), S aureus infections are increasingly being reported in community settings, especially in patients with HCAP. Recent surveillance of community-dwelling adults with pneumonia admitted to United States hospitals has demonstrated a steady increase in S aureus isolates. Thus, MRSA should be considered in severe pneumonia associated with influenza-like symptoms, particularly when accompanied by hemoptysis or leukopenia. However, MRSA pneumonia also can develop in the absence of preceding influenza-like illness. Effective empiric therapy for pneumonia, whether CAP or HCAP, mandates selection of an agent with coverage against all likely pathogens. Failure to provide adequate initial antimicrobial coverage has been associated with an increased risk of death. The spread of resistant pathogens in the community challenges currently available antimicrobial agents for effective treatment of MRSA-mediated pneumonia. Approval of newer antimicrobials with MRSA activity may provide additional options for the management of pneumonia. This article provides a review of the role of MRSA as a causative pathogen in CAP and HCAP.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.